The People Who Drive BioFabUSA
See ARMI|BioFabUSA’s dedicated Leadership Team, Board of Directors, Stakeholder Council and Leadership Advisory Council.
Leadership
Executive Director & Chairman of the Board
Deputy Executive Director & Secretary of the Board
M.D. Chief Operating Officer, ARMI
Ph.D., Chief Technology Officer
Ph.D., M.D., Chief Regulatory Officer
Chief Strategy Officer
Chief Innovation Officer
Chief Operating Officer, BioFabUSA
Board of Directors
Like-minded people—who are from different spheres but have changed the world in their own ways—make up ARMI’s board of directors.
ARMI Executive Director, DEKA CEO, serial inventor and FIRST founder
United Therapeutics CEO and Sirius Satellite Radio founder
Boston Scientific founder and medical device pioneer
Senior Vice President for Microsoft Healthcare, and former CEO of Dartmouth-Hitchcock
Rockwell Automation CEO and veterans and workforce-development champion
MIT Professor of the Practice, expert in manufacturing & systems of innovation
President of SUNY Polytechnic Institute, engineering thought leader
Stakeholder Council
The Stakeholder Council consists of the ARMI board of directors and key personnel from the U.S. Department of Defense.
Dr. Kate Sixt, Office of the Secretary of Defense
Kathleen Berst, Defense Health Agency
Keith DeVries, Office of the Under Secretary of Defense for Research and Engineering (OUSD(R&E))
Dr. Lloyd Rose, U.S. Army Medical Materiel Development Activity
Leadership Advisory Council
The Leadership Advisory Council (LAC) provides industry expertise and strategic guidance to the stakeholder council. BioFabUSA’s membership elects members of the council. Five of the members of the LAC also hold membership in the Technical Advisory Subcommittee (TASC).
Adam Jakus, Ph.D., BioThera
Anna K. Argo, MBA, Cytotheryx, Inc.
Benjamin H. Fryer, Ph.D., Pluristyx Inc.
Cato Laurencin, M.D., Ph.D., University of Connecticut (UConn)
Dave Mann, Ph.D., Vascugen, Inc.
David Kaplan, Ph.D., Tufts University
Doris A. Taylor Ph.D., FAHA, FACC, FESC, FAIMBE, OrganaMet Bio
Doug McConnell, MBA, Safi Biotherapeutics, Inc.
Eric R. Schuur, Ph.D., HepaTx Corporation
Esther Latres, Breakthrough T1D
Howard Federoff, MD, PhD, Kenai Therapeutics
Katherine Hixon, Ph.D., Dartmouth College
Mark Powers, Ph.D., Thermo Fisher Scientific, Inc.
Matt Weaver, Rockwell Automation, Inc.
Michael Golway, P.E., Advanced Solutions Life Sciences, LLC
Noemi Laboria, Ph.D., Festo Life Sciences
Sherine Elsawa, Ph.D., University of New Hampshire (UNH)
Steve Rees, Ph.D., Defined Bioscience, Inc.
